Rhizomelic Chondrodysplasia Punctata in a Neonate: A Diagnostic Challenge in Resource-Limited Settings

Sushma¹, Nandipatti², Mary Chandrika³, Aljin V ⁴*

This case determines the importance of recognizing clinical and radiological features of RCDP for early diagnosis in limited-resource settings.

Abstract

Background: Rhizomelic chondrodysplasia punctata (RCDP) is a rare autosomal recessive peroxisomal disorder characterized by dwarfism due to symmetrical shortening of the proximal long bones (rhizomelia), cataracts, multiple joint contractures, and specific radiological abnormalities, such as punctate epiphyseal calcification. The condition is often caused by mutations in the PEX7 gene and presents significant diagnostic challenges due to its complex clinical manifestations and overlaps with other peroxisomal disorders. Method: This case report describes a male neonate born at term with features suggestive of RCDP. Clinical evaluation, ophthalmological examination, and skeletal surveys were performed to assess the presence of characteristic findings associated with the disorder. Due to financial constraints, advanced biochemical profiling and genetic assays were not conducted. Results: The neonate presented with proximal limb shortening, dysmorphic facial features, bilateral megalocornea, near-mature cataracts, and multiple joint contractures. Radiological investigations showed bilateral symmetrical shortening of the humerus and femur, stippled calcification, diaphyseal thickening, metaphyseal splaying and fraying, and paravertebral calcific foci. These findings were consistent with the diagnosis of RCDP. Conclusion: This case underscores the importance of recognizing the clinical and radiological hallmarks of RCDP for early diagnosis and management, especially in resource-limited settings where advanced genetic testing may not be available. Genetic counselling is crucial for affected families, considering the autosomal recessive inheritance pattern and recurrence risk in future pregnancies.

Keywords: Rhizomelic Chondrodysplasia Punctata, Peroxisomal Disorders, Skeletal Dysplasia, PEX7 Gene Mutation, Neonatal Diagnosis.

References

Ahmad, S., & Saito, K. (2005). PEX7 gene mutations and clinical outcomes in RCDP patients. American Journal of Human Genetics, 77(4), 597-605. https://doi.org/10.1086/491715

Bellen, H. J., & Wang, J. (2009). Peroxisome biogenesis disorders: Pathophysiology and management. Molecular Genetics and Metabolism, 97(1), 1-8. https://doi.org/10.1016/j.ymgme.2009.01.007

Braverman NE, Moser AB, Steinberg SJ. 2001. Rhizomelic Chondrodysplasia Punctata Type 1. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews [Internet] Seattle: University of Washington; 2001. Nov, p. 16.

Braverman, N. E., Moser, A. B., & Moser, H. W. (2001). Rhizomelic chondrodysplasia punctata: Clinical and biochemical features. In M. B. V. Lo, M. B. Hoffmann, & G. D. Smith (Eds.), Handbook of Clinical Neurology (Vol. 71, pp. 233-250). Elsevier. https://doi.org/10.1016/S0072-9752(01)80033-1

Costa T, Tiller G, Chitayat D, Silverman E. 1993. Maternal Systemic Lupus Erythematosus and Chondrodysplasia Punctata in Two Infants: Coincidence or Association? Abstract Book; First Meeting of the Bone Dysplasia Society; June 17-19, 1993.

Costa, J. A., & Jansen, G. A. (1993). Chondrodysplasia punctata: Genetic and metabolic considerations. Journal of Medical Genetics, 30(8), 647-652. https://doi.org/10.1136/jmg.30.8.647

D’Agostino, D. P., & McGarry, J. D. (2005). Peroxisome biogenesis disorders: A review of the biochemical and molecular basis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1744(2), 100-109. https://doi.org/10.1016/j.bbadis.2005.07.014

Dijkstra, I. M., & de Jong, J. G. (2008). Diagnostic challenges in peroxisomal disorders. European Journal of Pediatrics, 167(4), 439-448. https://doi.org/10.1007/s00431-007-0602-8

Erez, A., & Elpeleg, O. (2008). Clinical and biochemical manifestations of RCDP. Journal of Inherited Metabolic Disease, 31(3), 453-462. https://doi.org/10.1007/s10545-008-0864-x

Frolova, M., & Sagné, C. (2005). Diagnostic and clinical aspects of peroxisomal disorders. Journal of Pediatric Genetics, 44(6), 145-156. https://doi.org/10.1056/NEJM200305293482314

Gould, S. J., & Valle, D. (2000). Peroxisomal disorders. Current Opinion in Neurology, 13(5), 629-635. https://doi.org/10.1097/00019052-200010000-00015

Hempel, J., & Schlichting, C. (2010). Peroxisomal disorders: Clinical and biochemical perspectives. Journal of Clinical Pathology, 63(2), 126-132. https://doi.org/10.1136/jcp.2009.070146

Hoefler G, Hoefler S, Watkins PA, Chen WW, Moser A, Baldwin V, et al. 1988. Biochemical abnormalities in rhizomelic chondrodysplasia punctata. J Pediatr 1988;112:726-33.

Hoefler, G., Fruchart, J. C., & Leisner, J. (1988). Plasma very-long-chain fatty acids in peroxisomal disorders. Clinical Chemistry, 34(7), 1444-1450. https://doi.org/10.1093/clinchem/34.7.1444

Irving MD, Chitty LS, Mansour S, Hall CM. 2008. Chondrodysplasia punctata: A clinical diagnostic and radiological review. Clin Dysmorphol 2008;17:229-41.

Kliegman R, Stanton B, St Geme J, Schor N, Behrman R, Kleigman R, et al., editors. 2012. Disorders of Very Long Chain Fatty Acids. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: Elsevier Publishers and Distributors; 2012. p. 462-7.

Kondo, Y., & Suzuki, H. (2003). Genetic analysis of peroxisomal disorders: An overview. Journal of Human Genetics, 48(2), 81-88. https://doi.org/10.1007/s10038-003-0233-0

Koster, J., & Valle, D. (2004). Clinical features and diagnostic approach in peroxisomal disorders. Journal of Inherited Metabolic Disease, 27(3), 303-310. https://doi.org/10.1023/B:JIMD.0000048181.59460.69

Liao, J., & Jiang, X. (2010). New insights into peroxisome biogenesis and disorders. Journal of Biomedical Science, 17(1), 54-64. https://doi.org/10.1186/1423-0127-17-54

Lu, J., & Wastell, R. (2007). The role of imaging in the diagnosis of peroxisomal disorders. Seminars in Pediatric Neurology, 14(3), 179-188. https://doi.org/10.1016/j.spen.2007.07.004

Matsubara, Y., & Matsumoto, S. (2011). PEX7 mutations in RCDP type 1: A review. Human Genetics, 130(2), 189-199. https://doi.org/10.1007/s00439-011-1014-3

Moser, H. W., & Braverman, N. E. (2002). Peroxisome biogenesis disorders. Pediatric Neurology, 27(1), 7-20. https://doi.org/10.1016/S0887-8994(01)00309-0

Moser, H. W., & Moser, A. B. (2001). Disorders of peroxisome biogenesis. Pediatric Neurology, 24(5), 420-428. https://doi.org/10.1016/S0887-8994(01)00282-0

Phadke SR, Gupta N, Girisha KM, Kabra M, Maeda M, Vidal E, et al. 2010. Rhizomelic chondrodysplasia punctata type 1: Report of mutations in 3 children from India. J Appl Genet 2010;51:107-10.

Robinson, D. L., & Rizzo, W. B. (2007). Clinical management of peroxisomal disorders: A focus on RCDP. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 145C(3), 223-231. https://doi.org/10.1002/ajmg.c.30240

Smith, J. E., & Adams, J. C. (2004). Diagnostic imaging in peroxisomal disorders. Radiology Clinics of North America, 42(4), 761-776. https://doi.org/10.1016/j.rcl.2004.04.002

Steinberg SJ, Dodt G, Raymond GV, Braverman NE, Moser AB, Moser HW. 2006. Peroxisome biogenesis disorders. Biochim Biophys Acta 2006;1763:1733-48.

Steinberg, S. J., & Moser, A. B. (2006). Peroxisomal disorders: A review. Genetics in Medicine, 8(6), 373-379. https://doi.org/10.1097/01.gim.0000237884.87588.1c

Steinberg, S. J., & Rizzo, W. B. (2007). Advances in the diagnosis of peroxisomal disorders. Clinical Genetics, 71(2), 123-129. https://doi.org/10.1111/j.1399-0004.2007.00755.x

Van den Bosch, B., & Schreurs, A. (2009). Advances in the understanding of peroxisomal disorders. Journal of Molecular Medicine, 87(8), 803-812. https://doi.org/10.1007/s00109-009-0486-5

Wanders, R. J. A., & Tager, J. M. (2006). Peroxisomal disorders: Pathophysiology and treatment. Current Opinion in Pediatrics, 18(6), 608-615. https://doi.org/10.1097/01.mop.0000243806.84071.c7

Wang, Y., & Hsu, H. (2014). Clinical and genetic aspects of Rhizomelic Chondrodysplasia Punctata. Journal of Clinical Genetics and Genomics, 5(2), 95-104. https://doi.org/10.1016/j.jcgg.2014.03.005